Both Stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6-induced apoptosis of 1A9-M cells

Blood

Volumn 93, Issue 4, 1999, Pages 1346-1354

  Oritani, Kenji ^a   Tomiyama, Yoshiaki ^b   Kincade, Paul W ^b   Aoyama, Keisuke ^b   Yokota, Takafumi ^b   Matsumura, Itaru ^b   Kanakura, Yuzuru ^b   Nakajima, Koichi ^b   Hirano, Toshio ^b   Matsuzawa, Yuji ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; DOWN REGULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033557944     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.4.1346     Document Type: Article

References (56)

1. Long MW: Blood cell cytoadhesion molecules. Exp Hematol 20:288, 1992
2. Kincade PW: Cell adhesion mechanisms utilized for lymphohemopoiesis, in Shimizu Y (ed): Lymphocyte Adhesion Molecules. Austin, TX, Landes, 1993, p 249
3. Verfaillie C, Hurley R, Bhatia R, McCarthy JB: Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit Rev Oncol Hematol 16:201, 1994
4. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW: A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 114:557, 1991
5. Miyake K, Weissman IL, Greengerger JS, Kincade PW: Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173:599, 1991
6. Miyake K, Medina K, Hayashi S-I, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171:477, 1990
7. Oritani K, Wu X, Medina K, Hudson J, Miyake K, Gimble JM, Burstein SA, Kincade PW: Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 87:2252, 1996
8. Pietrangeli CE, Hayashi S-I, Kincade PW: Stromal cell lines which support lymphocyte growth: Characterization. sensitivity to radiation and responsiveness to growth factors. Eur J Immunol 18:863, 1988
9. Kincade PW, Medina K, Pietrangeli CE, Hayashi S-I, Naemen AE: Stromal cell lines which support lymphocyte growth II. Characteristics of a suppressive subclone. Adv Exp Med Biol 292: 227, 1991
10. Van Snick J: Interleukin-6: An overview. Annu Rev Immunol 8:253, 1990
11. Hirano T: The biology of interleukin-6. Chem Immunol 51:153, 1992
12. Hirano T: Interleukin 6 and its receptor: Ten years later. Int Rev Immunol 16:249, 1998
13. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T: The essential role of B cell stimulatory factor-2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167:332, 1988
14. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto K, Okada N, Kishimoto T: Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83, 1988
15. Gauldie J, Richards C, Harnish D, Lansdrop P, Baumann H: Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251, 1987
16. Miyaura C, Onozaki K, Akiyama Y, Taniyama T, Hirano T, Kishimoto T, Suda T: Recombinant human interleukin 6 (B cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett 234:17, 1988
17. Oritani K, Kaisho T, Nakajima K, Hirano T: Retinoic acid inhibits interleukin 6-induced macrophage differentiation and apoptosis in a murine hematopoietic cell line, Y6. Blood 80:2298, 1992
18. Hibi M, Nakajima K. Hirano T: IL-6 cytokine family and signal transduction: A model of the cytokine system. J Mol Med 74:1, 1996
19. Ihle JN: STATs: Signal transducers and activators of transcription. Cell 84:331, 1996
20. Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T: Differentiation and growth arrest signals are generated through the cytoplasmic resion of gp130 that is essential for Stat3 activation. EMBO J 15:1557, 1996
21. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukuda T, Hibi M, Hirano T: A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15:3651, 1996
22. Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S: STAT3 activation is a critical step in gp 130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA 93:3963, 1996
23. Ishihara K, Medina K, Hayashi S, Pietrangeli C, Namen AE, Miyake K, Kincade PW: Stromal-cell and cytokine-dependent lymphocyte clones which span the pre-B-to B-cell transition. Dev Immunol 1:149, 1991
24. Nakajima K, Kusafuka T, Takeda T, Fujitani Y, Nakae K, Hirano T: Identification of a novel interleukin-6 response element containing an ETS-binding site and a CRE-like site in the JunB promoter. Mol Cel Biol 13:3027, 1993
25. Tsujimura T, Hashimoto K, Morii E, Tunio GM. Tsujino K, Kondo T, Kanakura Y, Kitamura Y: Involvement of transcription factor encoded by the mouse mi locus (MITF) in apoptosis of cultured mast cells induced by removal of interleukin-3. Am J Pathol 151:1043, 1997
26. Davidson WF, Pierce JH, Rudikoff S, Morse HC: Relationship between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med 168:389, 1988
27. Hara H, Sam M, Maki RA, Wu GE, Paige CJ: Characterization of a 7OZ/3 pre-B cell derived macrophage clone. Differential expression of Hox family gene. Int Immunol 2:691, 1990
28. Tanaka T, Wu GE, Paige CJ: Characterization of the B cell-macrophage lineage transition in 7OZ/3 cells. Eur J Immunol 24:1544, 1994
29. Bretz JD, Chen SC, Redenius D, Chang HL, Esselman WJ, Schwartz RC: Lineage switch macrophages can present antigen. Dev Immunol 2:249, 1992
30. Spencker T, Neumann D, Strasser A, Resch K, Martin M: Lineage switch of a mouse pre-B cell line (SPGM-1) to macrophage-like cells after incubation with phorhol ester and calcium ionophore. Biochem Biophys Res Commun 216:540, 1995
31. Klinken SP, Alexander WS, Adams JM: Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages. Cell 53:857, 1988
32. Borzillo GV, Ashmun RA, Sherr CJ: Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol Cell Biol 10:2703, 1990
33. Darnell JJ, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415, 1994
34. Meraz MA, White JM, Sheedhan KCF, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Gleenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD: Targeted disruption of the mouse Stall gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431, 1996
35. Durbin JE, Hachenmiller R, Simon MC, Levy DE: Targeted disruption of the mouse Stall gene results in compromised innate immunity to viral disease. Cell 84:443, 1996
36. Kaplan MH, Sun YL, Hoey T, Grusby MJ: Impaired IL12 responses and enhanced developmenl of Th2 cells in Stat4-deficient mice. Nature 382:174, 1996
37. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld GC. Ihle JN: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171, 1996
38. Shimoda K, van Deusen JM, Sangster MY, Sarwar SR, Carson RT, Tripp RA, Chu C, Qualle FW, Nosaka T, Vignali S, Doherty PC, Grosveld G, Paul W, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630, 1996
39. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signaling. Nature 380:627, 1996
40. Lutlicken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpar AG, Wilks AF, Yasukawa K, Taga T, Kishimoto T, Barbieri G, Pellegrini S, Sendtner M, Heinrich PC, Horn F: Association of transcription factor APRF and protein kinase Juk1 with the interleukin-6 signal transducer gp130. Science 263:89, 1994
41. Stahl N, Farrugella TJ, Boulton TG, Zhong Z, Darnell JE, Yancopoulas G: Choice of STATs and other substrates specified by modular tyrosine-based molifs in cytokine receptors. Science 267:1349, 1995
42. Fujitani Y, Nakajina K, Kojima H, Nakae K, Takeda T, Hirano T: Transcriptional activation of the IL-6 response element in the jun B promoter is mediated by multiple Stat family proteins. Biochem Biophys Res Commun 202:1181, 1994
43. Ellis RE: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663, 1991
44. Green DR, Bissonnette RP, Glynn JM, Shi Y: Activation-induced apoptosis in lymphoid systems. Semin Immunol 4:379, 1992
45. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097, 1991
46. Mangan DF, Wahl H: Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines. J Immunol 147:3408, 1991
47. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285, 1995
48. Benito A, Grillot D, Nunez G, Fernandez-Luna JL: Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 146:481, 1995
49. Sanz C, Benito A, Silva M, Albella B, Richard C, Segovia JC, Insunza A, Bueren JA, Fernandez-Luna JL: The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood 89:3199, 1997
50. Wilson BE, Mochon E, Boxer LM: Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16:5546, 1996
51. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095, 1994
52. Salomoni P, Perrotti D, Martinez R, Franceschi C, Calabretta B: Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Mybdependent regulation of bcl-2 promoter activity. Proc Natl Acad Sci USA 94:3296, 1997
53. Fukada T, Hibi M, Yamanaka Y, Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T: Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5:449, 1996
54. Nakajima K, Matsuda T, Fujitani Y, Kojima H, Yamanaka Y, Nakae K, Takada T, Hirano T: Signal transduction through IL-6 receptor: Involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann NY Acad Sci 762:55, 1995
55. INK4D with IL-6-induced growth arrest. Biochem Biophys Res Commun 238:764, 1997
56. Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N, Hirano T: Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element binding protein. J Biol Chem 273:6132, 1998